VMD.TO - Viemed Healthcare, Inc.

Toronto - Toronto Delayed Price. Currency in CAD
10.90
-0.20 (-1.80%)
As of 9:35AM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close11.10
Open11.01
Bid10.80 x 0
Ask10.91 x 0
Day's Range10.58 - 11.01
52 Week Range3.71 - 11.49
Volume22,913
Avg. Volume108,458
Market Cap411.32M
Beta (3Y Monthly)N/A
PE Ratio (TTM)45.42
EPS (TTM)0.24
Earnings DateNov 4, 2019 - Nov 8, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est9.47
  • Thomson Reuters StreetEvents

    Edited Transcript of VMD.TO earnings conference call or presentation 9-Aug-19 3:00pm GMT

    Q2 2019 Viemed Healthcare Inc Earnings Call

  • GlobeNewswire

    Viemed Healthcare Announces Financial Results for Second Quarter 2019

    LAFAYETTE, La., Aug. 09, 2019 -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX: VMD.TO and NASDAQ:VMD), a home medical equipment supplier that provides post-acute.

  • GlobeNewswire

    Viemed Healthcare Announces Listing on Nasdaq Capital Market

    Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX:VMD.TO), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced that its common shares were approved for listing on the Nasdaq Capital Market. Trading on the Nasdaq Capital Market under the ticker symbol “VMD” is expected to commence tomorrow, August 9, 2019. The Company’s common shares are also traded on the Toronto Stock Exchange under the ticker symbol “VMD.TO” and will continue to trade on that exchange.

  • GlobeNewswire

    Viemed Healthcare Announces Date and Time for Conference Call

    LAFAYETTE, La., Aug. 07, 2019 -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX:VMD.TO), a home medical equipment supplier that provides post-acute respiratory care.

  • Does Viemed Healthcare (TSE:VMD) Have A Healthy Balance Sheet?
    Simply Wall St.

    Does Viemed Healthcare (TSE:VMD) Have A Healthy Balance Sheet?

    The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

  • Viemed Healthcare, Inc. (TSE:VMD) Delivered A Better ROE Than Its Industry
    Simply Wall St.

    Viemed Healthcare, Inc. (TSE:VMD) Delivered A Better ROE Than Its Industry

    While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

  • Thomson Reuters StreetEvents

    Edited Transcript of VMD.TO earnings conference call or presentation 7-May-19 3:00pm GMT

    Q1 2019 Viemed Healthcare Inc Earnings Call

  • What Kind Of Shareholder Owns Most Viemed Healthcare, Inc. (TSE:VMD) Stock?
    Simply Wall St.

    What Kind Of Shareholder Owns Most Viemed Healthcare, Inc. (TSE:VMD) Stock?

    Every investor in Viemed Healthcare, Inc. (TSE:VMD) should be aware of the most powerful shareholder groups...

  • GlobeNewswire

    Viemed Healthcare Announces Voting Results From Its Annual General Meeting of Shareholders

    LAFAYETTE, La., May 13, 2019 -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX:VMD), a home medical equipment supplier that provides post-acute respiratory care.

  • GlobeNewswire

    Viemed Healthcare Announces First Quarter 2019 Financial Results

    Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX:VMD.TO), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced today that its financial statements for the three months ended March 31, 2019 and accompanying Management's Discussion & Analysis (MD&A) have been filed on SEDAR and are available at www.sedar.com. The Company grew its ventilator patient count by approximately 36% as compared to prior year’s comparable quarter and 8% over fourth quarter 2018. Capital expenditures totaled $4.5 million for the quarter ended March 31, 2019.

  • GlobeNewswire

    Viemed Healthcare to Present at The Bloom Burton & Co. Healthcare Investor Conference in Toronto

    LAFAYETTE, La., April 18, 2019 -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX:VMD:TO), a home medical equipment supplier that provides post-acute respiratory care.

  • Is Viemed Healthcare, Inc.'s (TSE:VMD) P/E Ratio Really That Good?
    Simply Wall St.

    Is Viemed Healthcare, Inc.'s (TSE:VMD) P/E Ratio Really That Good?

    Today, we'll introduce the concept of the P/E ratio for those who are learning about investing. We'll apply a basic P/E ratio analysis to Viemed Healthcare, Inc.'s (TSE:VMD), to help you decide if the stock is worth further researc...

  • GlobeNewswire

    Viemed Healthcare Announces Increased Commercial Loan Agreement

    Viemed Healthcare, Inc. (the “Company” or “Viemed”) (VMD.TO), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced today that it has entered into an amendment to its two year commercial business loan agreement increasing the line of credit to $10 million. The agreement is with WHITNEY BANK, a Mississippi state chartered bank, will carry an interest rate that is based on one month ICE LIBOR plus 3.00% per annum from date of advance until paid and any amounts advanced will be secured by substantially all of the Company’s assets. “We are pleased to announce the increase in our line of credit to $10 million which gives us more liquidity as we continue our rapid growth around the country,” stated Casey Hoyt, Viemed CEO.

  • GlobeNewswire

    Viemed Healthcare Announces Upcoming Investor Webcast and Spring Investor Summit Participation

    Viemed Healthcare, Inc. (the “Company” or “Viemed”) (VMD.V), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced today  that it will host an investor webcast presentation on Wednesday, March 27th, 2019 at 11:00AM EST, and will be presenting at the Spring Investor Summit on April 1st in New York City at the Essex House. During the investor webcast on March 27th, at 11am EST, Casey Hoyt, CEO, and Todd Zehnder, COO, will conduct an introductory presentation for investors that are new to Viemed Healthcare or looking to gain more insight into the business.  The presentation will cover key areas of the business including technology, services and solutions, the current state of the industry, expected market trends, recent results, growth strategy and future objectives.  The presentation will also include a question and answer session giving investors an opportunity to expand their understanding of the business.

  • GlobeNewswire

    Viemed Healthcare Comments on Competitive Bidding Announcement

    Viemed Healthcare, Inc. (the “Company” or “Viemed”) (VMD.TO), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announces that it is aware of the recent announcement by the Centers for Medicare and Medicaid Services (CMS) that Non-invasive ventilators (NIV) will be included in the next round of Competitive Bidding Program (CBP) expected to begin in 2021. It appears as though the current suspension of the CBP program will continue until 2021, and the 130 areas that were included in the latest rounds of CBP are going to be the areas included during 2021. The Company is currently serving CMS patients in 39 of these CBP areas, and it currently expects that it will continue to expand its patient base in those areas as well as additional CBP areas during its current geographical expansion.

  • Thomson Reuters StreetEvents

    Edited Transcript of VMD.TO earnings conference call or presentation 28-Feb-19 4:00pm GMT

    Q4 2018 Viemed Healthcare Inc Earnings Call

  • Thomson Reuters StreetEvents

    Edited Transcript of VMD.TO earnings conference call or presentation 13-Mar-18 1:30pm GMT

    Q4 2017 Viemed Healthcare Inc Earnings Call

  • Thomson Reuters StreetEvents

    Edited Transcript of VMD.TO earnings conference call or presentation 8-May-18 3:00pm GMT

    Q1 2018 Viemed Healthcare Inc Earnings Call

  • GlobeNewswire

    Viemed Healthcare Announces 2018 Record Financial Results

    Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX:VMD.TO), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced today that its financial statements for the three months and year ended December 31, 2018 and accompanying Management's Discussion & Analysis (MD&A) have been filed on SEDAR and are available at www.sedar.com. The Company grew its ventilator patient count by approximately 35% as compared to prior year and 8% over third quarter 2018. Capital expenditures totaled $14.5 million for the year ended December 31, 2018.

  • Viemed Healthcare, Inc. (TSE:VMD) Insiders Have Been Selling
    Simply Wall St.

    Viemed Healthcare, Inc. (TSE:VMD) Insiders Have Been Selling

    Want to participate in a short research study? Help shape the future of investing tools and receive a $20 prize! We often see insiders buying up shares in companies thatRead More...

  • GlobeNewswire

    Viemed Healthcare Announces 2018 Preliminary Financial Results and Date and Time for Conference Call

    Viemed Healthcare, Inc. (the “Company” or “Viemed”) (TSX:VMD), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announced today that it expects to post final year end December 31, 2018 results on SEDAR on or before February 28, 2019. Preliminary results show annual revenue to be approximately US$65.2-$65.3 million and Adjusted EBITDA to be in the range of US$17.2-17.3 million.  These results are preliminary, and are subject to Change, following completion of the independent audit and management’s year-end audit review process. Additionally, the Company announced today that it will host its Quarterly Conference Call on Thursday, February 28, 2019 at 11:00 a.m. EST.

  • How Financially Strong Is Viemed Healthcare, Inc. (TSE:VMD)?
    Simply Wall St.

    How Financially Strong Is Viemed Healthcare, Inc. (TSE:VMD)?

    While small-cap stocks, such as Viemed Healthcare, Inc. (TSE:VMD) with its market cap of CA$208m, are popular for their explosive growth, investors should also be aware of their balance sheet Read More...

  • Is Viemed Healthcare, Inc.’s (TSE:VMD) ROE Of 22% Impressive?
    Simply Wall St.

    Is Viemed Healthcare, Inc.’s (TSE:VMD) ROE Of 22% Impressive?

    While some investors are already well versed in financial metrics (hat tip), this article is for those who would like to learn about Return On Equity (ROE) and why it Read More...

  • GlobeNewswire

    Viemed Healthcare Announces Acceptance by TSX of Normal Course Issuer Bid

    Viemed Healthcare, Inc. (the “Company” or “Viemed”) (VMD.TO), a home medical equipment supplier that provides post-acute respiratory care services in the United States, announces that the Toronto Stock Exchange (the “TSX”) has approved the Company's notice of intention to commence a normal course issuer bid (the “Bid”). Under the terms of the Bid, Viemed may acquire up to 1,895,575 common shares of the Company (the “Common Shares”) from time to time in accordance with TSX procedures, representing approximately 5% of the total issued and outstanding Common Shares as at November 23, 2018.